EVEX Hospitals Joins Clinerion’s Patient Network Explorer
EVEX Hospitals joins the international hospital network on Clinerion’s Patient Network Explorer platform, bringing their patients to the attention of researchers and trial sponsors who are recruiting for clinical trials. This offers the hospitals’ patients’ earlier access to treatments and medications in Georgia.
EVEX Hospitals is the group member of Georgia Healthcare Group (GHG). GHG is the largest healthcare service provider in Georgia, with 23% market share by number of referral hospitals and community clinics beds (3,320). GHG offers a comprehensive range of inpatient and outpatient services through an integrated network of hospitals and clinics. EVEX Hospitals has a strong background in running clinical trials, with high integrity data; productive, reliable site operations; rapid country and site startup; and established ethics compliance standards across its sites.
Joining Patient Network Explorer, EVEX Hospitals’ patients and their treating physicians gain increased treatment options and access to new medical interventions. Patients will be matched to clinical studies according to their electronic health records, ensuring better screening when recruiting for clinical trials. Trial managers gain the ability to include eligible patients for trials more quickly and efficiently than before.
“We are pleased with our strong expansion in Georgia, which means we have a good representation and coverage of the country,” says Ian Rentsch, CEO of Clinerion. “This makes the services that we offer for Georgia more statistically meaningful to researchers and clinical trial managers at Pharma sponsors and CRO.”
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Landmark Phase III Trial Shows Keytruda Significantly Improves Event-Free Survival in LA-HNSCC
April 28th 2025Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or recurrence in resectable, locally advanced head and neck squamous cell carcinoma, marking the first major clinical advance for this patient population in more than two decades.
